Ligation of Fc gamma receptor IIB inhibits antibody-dependent enhancement of dengue virus infection. - Wikidata - wikimedia - TriplyDB

Ligation of Fc gamma receptor IIB inhibits antibody-dependent enhancement of dengue virus infection.

Ligation of Fc gamma receptor IIB inhibits antibody-dependent enhancement of dengue virus infection.

http://www.wikidata.org/entity/Q35133990

about

Feasibility of cross-protective vaccination against flaviviruses of the Japanese encephalitis serocomplex Structure-Guided Design of an Anti-dengue Antibody Directed to a Non-immunodominant Epitope Fc receptors and their influence on efficacy of therapeutic antibodies for treatment of viral diseases Dengue E Protein Domain III-Based DNA Immunisation Induces Strong Antibody Responses to All Four Viral Serotypes Quaking promotes monocyte differentiation into pro-atherogenic macrophages by controlling pre-mRNA splicing and gene expression.Rational design of a live attenuated dengue vaccine: 2'-o-methyltransferase mutants are highly attenuated and immunogenic in mice and macaques How antibodies alter the cell entry pathway of dengue virus particles in macrophages Dengue: an update on treatment options Sequence diversity of dengue virus type 2 in brain and thymus of infected interferon receptor ko mice: implications for dengue virulence Sulfated polysaccharide, curdlan sulfate, efficiently prevents entry/fusion and restricts antibody-dependent enhancement of dengue virus infection in vitro: a possible candidate for clinical application Production of Infectious Dengue Virus in Aedes aegypti Is Dependent on the Ubiquitin Proteasome Pathway Proteasome Inhibition Suppresses Dengue Virus Egress in Antibody Dependent Infection Dengue virus compartmentalization during antibody-enhanced infection.Dengue virus activates cGAS through the release of mitochondrial DNA First experimental in vivo model of enhanced dengue disease severity through maternally acquired heterotypic dengue antibodies Maternal Antibody-Mediated Disease Enhancement in Type I Interferon-Deficient Mice Leads to Lethal Disease Associated with Liver Damage Hypoxia enhances antibody-dependent dengue virus infection Delineating antibody recognition against Zika virus during natural infection Down-regulation of complement receptors on the surface of host monocyte even as in vitro complement pathway blocking interferes in dengue infection.Review article: Research on dengue during World War II revisited.Dendritic cells in dengue virus infection: targets of virus replication and mediators of immunity.Dengue virus neutralization in cells expressing Fc gamma receptors Detection of serotype-specific antibodies to the four dengue viruses using an immune complex binding (ICB) ELISA Dengue viruses are enhanced by distinct populations of serotype cross-reactive antibodies in human immune sera.The role of pre-existing cross-reactive antibodies in determining the efficacy of vaccination in humans: study protocol for a randomized controlled trial Dengue subgenomic RNA binds TRIM25 to inhibit interferon expression for epidemiological fitness.CD8+ T Cells Can Mediate Short-Term Protection against Heterotypic Dengue Virus Reinfection in Mice.Blockade of p-selectin is sufficient to reduce MHC I antibody-elicited monocyte recruitment in vitro and in vivo.Human FcγRII cytoplasmic domains differentially influence antibody-mediated dengue virus infection.Molecular determinants of plaque size as an indicator of dengue virus attenuation LILR-B1 blocks activating FcγR signaling to allow antibody dependent enhancement of dengue virus infection.Leukocyte immunoglobulin-like receptor B1 is critical for antibody-dependent dengue.The human antibody response to dengue virus infection Molecular mechanisms involved in antibody-dependent enhancement of dengue virus infection in humans.Diagnosis of dengue: an update.Therapeutic antibodies as a treatment option for dengue fever.Human gene copy number variation and infectious disease.Fc receptors in antibody-dependent enhancement of viral infections.Paradoxical role of antibodies in dengue virus infections: considerations for prophylactic vaccine development.Identification of cytotoxic T lymphocyte epitopes in dengue virus serotype 1.

P2860

Q24737461-1AD3DDBC-DCE7-42F6-BFE4-8B2820C93B6D Q26700120-F507A3FB-BEA1-4555-B1D5-73AEF2783A13 Q26783175-E7D9FC62-419D-4B14-9E58-A2700D3765BA Q27304342-49CC8861-C99A-43A0-A023-137BA98EB02E Q27328830-30791C3F-A2C9-4F2E-B1DD-B5F706A260B5 Q27334248-B9C0ACA0-DDEE-4D96-900A-5B534D839D1E Q27334575-8B1CE1E8-A5CF-4600-BEEC-C2F3F7AD12FD Q28085044-097EB3EA-3BB5-4B82-842A-38C577A958C0 Q28119688-4ACB325D-B9C2-44AF-B674-36C3E973ED4B Q28486916-CF05ED8D-2BDF-4C37-A486-75D0DF5AFAC8 Q28550947-964E6D28-251B-4AE2-BBDB-8BEF69A6E4DD Q28550953-3DB1C287-D2B7-432B-AB69-D99ADFD49DA2 Q30834861-CB2DB02A-C299-4184-A255-894FB4D21425 Q30855840-DABFB958-9E07-4A5B-98EC-11D908A8C82F Q31156754-34C5977D-0BCF-443E-9B19-08A65D35B73A Q33430984-54BA5AB4-50CC-4A15-8506-F156B760563B Q33679954-5125C3A9-34AA-46BD-ADD0-3712B3752BE6 Q33798068-25B09121-8FE0-4D7C-8B45-E4B632ED6A7C Q33951623-5E1F97BA-F97C-4CDB-98F1-F92C7B09BBCC Q34640272-783E8E10-D1AC-42D1-B5DF-1C5B1070DFFF Q34722528-021E4B2E-E47D-4079-A799-AC7C15270A12 Q34746693-41E18833-5629-4DF7-80C2-58CA1D07A2B2 Q35081258-8279A46C-21CD-4B8D-9ACF-A0957900A54B Q35294150-2EE094BA-C8E7-4D88-9FC1-98032AB769D1 Q35496004-8C978491-69CD-4BB8-8092-3ADC1ABECBE2 Q35681720-1366398A-E620-4F53-BEAB-46311C033308 Q35760439-EB5A8785-41CF-421C-8940-401D6F15A82F Q36584512-436D8421-0F56-47D6-9AF4-BE89578765C6 Q36862433-4ECC2255-EC0E-48F3-9A2D-AFC4D239BC9B Q36906525-EAC6091F-927E-4784-B7D7-C92066A18DA2 Q37599853-AD226387-E98B-41D0-8317-BBA9D9671B2A Q37599913-D6FF1ACF-7C88-4323-9AAC-B39A8CEEBCB0 Q37987124-F47A106B-53C9-41CF-AAAC-765090EE4A31 Q38045381-AC17E356-9A3B-462B-9338-FC23EC02B77E Q38048849-FD22EC91-C155-4789-8427-3CCABEEB0817 Q38149195-8A5A7C8D-E484-4FCF-962C-C80351FD96F4 Q38238690-EADFD4A3-2328-4545-B05A-60C85C36A089 Q38615396-7DE947F5-A5C1-417F-86A5-99D821BB20FE Q38636217-282C9D8B-74F9-41C5-BD70-288358AF123E Q38899058-1774ECCB-0C97-488D-80D5-0C07FE93A007

P2860

Ligation of Fc gamma receptor IIB inhibits antibody-dependent enhancement of dengue virus infection.

http://www.wikidata.org/entity/Q35133990

description

2011 nî lūn-bûn

@nan

2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Ligation of Fc gamma receptor ...... ent of dengue virus infection.

@ast

Ligation of Fc gamma receptor ...... ent of dengue virus infection.

@en

type

label

Ligation of Fc gamma receptor ...... ent of dengue virus infection.

@ast

Ligation of Fc gamma receptor ...... ent of dengue virus infection.

@en

prefLabel

Ligation of Fc gamma receptor ...... ent of dengue virus infection.

@ast

Ligation of Fc gamma receptor ...... ent of dengue virus infection.

@en

P1433

Q35133990-D63EC027-F39E-4997-9870-491EB54FAF1D

P1476

Q35133990-B19A2366-2819-460B-B1A9-41BB5AD20D32

P2093

Q35133990-134DB75C-2624-494E-A4E7-48E562225388

Q35133990-35C539B3-8152-4A63-8125-139246055D22

Q35133990-5F841569-0A5D-4E6F-A3A3-50805FA526D1

Q35133990-A5160945-0047-4929-AE4B-2DB8BD52671A

Q35133990-B2BDD956-69A3-42BD-A446-A4860689FDBF

Q35133990-BFD200B2-9CC7-4150-8BDB-91A546251357

Q35133990-ECC250FE-4CB9-428F-8930-327C52191180

P2860

Q35133990-058354B0-170F-496B-A222-C05CEDB39316

Q35133990-067523D9-481B-4F2A-B5A7-60CA356D9D6F

Q35133990-11D3B524-7C14-40C1-BA22-FC32FE652FDF

Q35133990-12199668-0B96-48A2-96F6-316598853D00

Q35133990-1545A37E-9447-41F2-AFED-BF09A30098AE

Q35133990-18E9F9E0-9C14-43D0-A9C5-19E4E2C38981

Q35133990-1D785006-1130-4A73-94FF-B251943F52B4

Q35133990-1F52B1D3-C353-46E8-9397-BA19AB29A531

Q35133990-26014171-B75D-4A32-9D78-8AB82F304C9F

Q35133990-2B44A8BD-0AC8-44AA-B188-0FA3DFBFE819

P304

Q35133990-DDF9478E-AD4E-4A2F-AFC2-7824F0D49B70

P31

Q35133990-CDDE25B1-5D62-42FC-829D-9D807D68C577

P356

Q35133990-773C5C2A-9C3E-4D1F-A245-11BCC5D350AA

P407

Q35133990-71644ABC-EF66-4244-854E-5F2D5F1780DF

P433

Q35133990-774FDE30-2A79-4D37-B5C6-100883709D31

P478

Q35133990-299193CA-6E7A-4E7D-A203-04EEB6D42A24

P50

Q35133990-03C47796-8973-4934-A753-AAD7DBA241A6

Q35133990-7005F9CE-770C-4C5B-9624-5B8FED00D46A

P577

Q35133990-E5E8645E-E6B8-4247-9764-D30711AA8FC8

P5875

Q35133990-BC3BD4FE-B9B6-4272-BCBE-94722B4A92D1

P698

Q35133990-121EB8DD-E6D5-47BB-ABC3-D362740A797A

P921

Q35133990-2B64914B-0C86-4709-92B7-BA491FD2AD5C

Q35133990-5617EFC0-0FBB-4054-8A9E-129A848F8004

P932

Q35133990-3160646E-6E65-402E-A829-CE192816D972

P356

PNAS.1106568108

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Ligation of Fc gamma receptor ...... ent of dengue virus infection.

@en

P2093

Angelia Chow

http://www.w3.org/2001/XMLSchema#string

Angeline Pei Chiew Lim

http://www.w3.org/2001/XMLSchema#string

Brendon J Hanson

http://www.w3.org/2001/XMLSchema#string

Hwee Cheng Tan

http://www.w3.org/2001/XMLSchema#string

Kuan Rong Chan

http://www.w3.org/2001/XMLSchema#string

Subhash G Vasudevan

http://www.w3.org/2001/XMLSchema#string

Ying Kai Chan

http://www.w3.org/2001/XMLSchema#string

P2860

DC-SIGN (CD209) mediates dengue virus infection of human dendritic cells

Monoclonal antibody-mediated enhancement of dengue virus infection in vitro and in vivo and strategies for prevention

Dissecting the cell entry pathway of dengue virus by single-particle tracking in living cells

Monoclonal Antibodies That Bind to Domain III of Dengue Virus E Glycoprotein Are the Most Efficient Blockers of Virus Adsorption to Vero Cells

Characterization of the early events in dengue virus cell entry by biochemical assays and single-virus tracking.

Type- and Subcomplex-Specific Neutralizing Antibodies against Domain III of Dengue Virus Type 2 Envelope Protein Recognize Adjacent Epitopes

Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody

The Stoichiometry of Antibody-Mediated Neutralization and Enhancement of West Nile Virus Infection

Molecular mechanisms of antibody-mediated neutralisation of flavivirus infection

Structural Insights into the Mechanisms of Antibody-Mediated Neutralization of Flavivirus Infection: Implications for Vaccine Development

P304

12479-12484

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.1106568108

http://www.w3.org/2001/XMLSchema#string

P407

P433

30

http://www.w3.org/2001/XMLSchema#string

P478

108

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-07-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51483522

http://www.w3.org/2001/XMLSchema#string

P698

21746897

http://www.w3.org/2001/XMLSchema#string

P921

P932

3145677

http://www.w3.org/2001/XMLSchema#string